USD 3.12
(-11.36%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 25.02 Million USD | -21.53% |
2022 | 31.89 Million USD | 15.18% |
2021 | 27.69 Million USD | -48.62% |
2020 | 53.89 Million USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q3 | 21.03 Million USD | -2.36% |
2024 Q1 | 24.51 Million USD | -2.05% |
2024 Q2 | 23.97 Million USD | -2.2% |
2023 Q2 | 28.69 Million USD | -2.52% |
2023 FY | 25.02 Million USD | -21.53% |
2023 Q1 | 29.44 Million USD | -7.69% |
2023 Q4 | 25.02 Million USD | 6.91% |
2023 Q3 | 23.4 Million USD | -18.43% |
2022 Q2 | 32.16 Million USD | 1.51% |
2022 Q1 | 31.68 Million USD | 14.43% |
2022 FY | 31.89 Million USD | 15.18% |
2022 Q4 | 31.89 Million USD | -0.29% |
2022 Q3 | 31.98 Million USD | -0.56% |
2021 FY | 27.69 Million USD | -48.62% |
2021 Q1 | - USD | -100.0% |
2021 Q4 | 27.69 Million USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2020 FY | 53.89 Million USD | 0.0% |
2020 Q4 | 53.89 Million USD | 112.31% |
2020 Q3 | 25.38 Million USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2018 FY | - USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Abbott Laboratories | 15.87 Billion USD | 99.842% |
Allurion Technologies Inc. | 41.85 Million USD | 40.208% |
Artivion, Inc. | 359.34 Million USD | 93.035% |
Avanos Medical, Inc. | 209.1 Million USD | 88.031% |
Butterfly Network, Inc. | 25.02 Million USD | 0.0% |
Bio-Rad Laboratories, Inc. | 1.4 Billion USD | 98.22% |
Boston Scientific Corporation | 9.49 Billion USD | 99.736% |
Perspective Therapeutics, Inc. | - USD | -Infinity% |
CONMED Corporation | 991.25 Million USD | 97.475% |
Edwards Lifesciences Corporation | 694.9 Million USD | 96.398% |
Paragon 28, Inc. | 112.03 Million USD | 77.66% |
Glaukos Corporation | 383.73 Million USD | 93.478% |
Globus Medical, Inc. | 520.4 Million USD | 95.191% |
Inspire Medical Systems, Inc. | 24.84 Million USD | -0.728% |
Integer Holdings Corporation | 1.04 Billion USD | 97.596% |
Medtronic plc | 26.04 Billion USD | 99.904% |
Nevro Corp. | 221.82 Million USD | 88.718% |
Owlet, Inc. | 15.21 Million USD | -64.478% |
Penumbra, Inc. | 234.34 Million USD | 89.32% |
Vicarious Surgical Inc. | 14.83 Million USD | -68.737% |
Smith & Nephew plc | 3.08 Billion USD | 99.188% |
Sonendo, Inc. | 40.35 Million USD | 37.977% |
STERIS plc | 3.38 Billion USD | 99.26% |
Stryker Corporation | 12.99 Billion USD | 99.807% |
Vapotherm, Inc. | 112.39 Million USD | 77.732% |
Zimmer Biomet Holdings, Inc. | 5.99 Billion USD | 99.583% |